Cargando…

Cohort profile: life with neurofibromatosis 1 – the Danish NF1 cohort

PURPOSE: The Danish neurofibromatosis 1 (NF1) cohort was initiated to study health-related, socioeconomic and psychological consequences of living with the monogenetic disorder NF1 using a nationwide and population-based approach. PARTICIPANTS: The cohort includes all 2467 individuals in Denmark who...

Descripción completa

Detalles Bibliográficos
Autores principales: Doser, Karoline, Hove, Hanne, Østergaard, John R, Bidstrup, Pernille E, Dalton, Susanne O, Handrup, Mette Møller, Ejerskov, Cecilie, Krøyer, Anja, Doherty, Mia Aagaard, Møllegaard Jepsen, Jens Richardt, Mulvihill, John J, Winther, Jeanette F, Kenborg, Line
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490603/
https://www.ncbi.nlm.nih.gov/pubmed/36127120
http://dx.doi.org/10.1136/bmjopen-2022-065340
_version_ 1784793120971423744
author Doser, Karoline
Hove, Hanne
Østergaard, John R
Bidstrup, Pernille E
Dalton, Susanne O
Handrup, Mette Møller
Ejerskov, Cecilie
Krøyer, Anja
Doherty, Mia Aagaard
Møllegaard Jepsen, Jens Richardt
Mulvihill, John J
Winther, Jeanette F
Kenborg, Line
author_facet Doser, Karoline
Hove, Hanne
Østergaard, John R
Bidstrup, Pernille E
Dalton, Susanne O
Handrup, Mette Møller
Ejerskov, Cecilie
Krøyer, Anja
Doherty, Mia Aagaard
Møllegaard Jepsen, Jens Richardt
Mulvihill, John J
Winther, Jeanette F
Kenborg, Line
author_sort Doser, Karoline
collection PubMed
description PURPOSE: The Danish neurofibromatosis 1 (NF1) cohort was initiated to study health-related, socioeconomic and psychological consequences of living with the monogenetic disorder NF1 using a nationwide and population-based approach. PARTICIPANTS: The cohort includes all 2467 individuals in Denmark who were hospitalised with or due to NF1 from 1977 to 2013 or registered in the RAREDIS Database (1995–2013), a national clinical database for rare diseases, or both. A comparison cohort matched to individuals with NF1 on sex and date of birth was identified in the Civil Registration System (n=20 132). FINDINGS TO DATE: All cohort members were linked to the unique Danish registries to obtain information on hospital contacts, birth outcomes, education and partnership. A questionnaire was completed by 244 of the 629 adult cohort members with NF1 registered in the RAREDIS Database to evaluate the psychosocial and emotional burden. Further, neuropsychological tests were performed on 103 adult cohort members with NF1 and 38 adult population comparisons. To date, six studies have been published. Individuals with NF1 had an increased risk for (1) hospitalisation for disorders affecting all organ systems of the body throughout all decades of life, (2) psychiatric disorders, (3) attaining a short or medium long education and (4) not forming a life partner. Women with NF1 had an increased risk for spontaneous abortions and stillbirths. Finally, adults with NF1 had an impaired quality of life and a high need for professional support for physical, psychological and work-related problems, which was partly associated with disease severity and visibility. FUTURE PLANS: The cohort will regularly be updated with newly diagnosed patients in the RAREDIS Database as well as with outcome information in the Danish registries. New studies are in progress to assess other medical and socioeconomic dimensions of living with NF1.
format Online
Article
Text
id pubmed-9490603
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-94906032022-09-22 Cohort profile: life with neurofibromatosis 1 – the Danish NF1 cohort Doser, Karoline Hove, Hanne Østergaard, John R Bidstrup, Pernille E Dalton, Susanne O Handrup, Mette Møller Ejerskov, Cecilie Krøyer, Anja Doherty, Mia Aagaard Møllegaard Jepsen, Jens Richardt Mulvihill, John J Winther, Jeanette F Kenborg, Line BMJ Open Epidemiology PURPOSE: The Danish neurofibromatosis 1 (NF1) cohort was initiated to study health-related, socioeconomic and psychological consequences of living with the monogenetic disorder NF1 using a nationwide and population-based approach. PARTICIPANTS: The cohort includes all 2467 individuals in Denmark who were hospitalised with or due to NF1 from 1977 to 2013 or registered in the RAREDIS Database (1995–2013), a national clinical database for rare diseases, or both. A comparison cohort matched to individuals with NF1 on sex and date of birth was identified in the Civil Registration System (n=20 132). FINDINGS TO DATE: All cohort members were linked to the unique Danish registries to obtain information on hospital contacts, birth outcomes, education and partnership. A questionnaire was completed by 244 of the 629 adult cohort members with NF1 registered in the RAREDIS Database to evaluate the psychosocial and emotional burden. Further, neuropsychological tests were performed on 103 adult cohort members with NF1 and 38 adult population comparisons. To date, six studies have been published. Individuals with NF1 had an increased risk for (1) hospitalisation for disorders affecting all organ systems of the body throughout all decades of life, (2) psychiatric disorders, (3) attaining a short or medium long education and (4) not forming a life partner. Women with NF1 had an increased risk for spontaneous abortions and stillbirths. Finally, adults with NF1 had an impaired quality of life and a high need for professional support for physical, psychological and work-related problems, which was partly associated with disease severity and visibility. FUTURE PLANS: The cohort will regularly be updated with newly diagnosed patients in the RAREDIS Database as well as with outcome information in the Danish registries. New studies are in progress to assess other medical and socioeconomic dimensions of living with NF1. BMJ Publishing Group 2022-09-20 /pmc/articles/PMC9490603/ /pubmed/36127120 http://dx.doi.org/10.1136/bmjopen-2022-065340 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology
Doser, Karoline
Hove, Hanne
Østergaard, John R
Bidstrup, Pernille E
Dalton, Susanne O
Handrup, Mette Møller
Ejerskov, Cecilie
Krøyer, Anja
Doherty, Mia Aagaard
Møllegaard Jepsen, Jens Richardt
Mulvihill, John J
Winther, Jeanette F
Kenborg, Line
Cohort profile: life with neurofibromatosis 1 – the Danish NF1 cohort
title Cohort profile: life with neurofibromatosis 1 – the Danish NF1 cohort
title_full Cohort profile: life with neurofibromatosis 1 – the Danish NF1 cohort
title_fullStr Cohort profile: life with neurofibromatosis 1 – the Danish NF1 cohort
title_full_unstemmed Cohort profile: life with neurofibromatosis 1 – the Danish NF1 cohort
title_short Cohort profile: life with neurofibromatosis 1 – the Danish NF1 cohort
title_sort cohort profile: life with neurofibromatosis 1 – the danish nf1 cohort
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490603/
https://www.ncbi.nlm.nih.gov/pubmed/36127120
http://dx.doi.org/10.1136/bmjopen-2022-065340
work_keys_str_mv AT doserkaroline cohortprofilelifewithneurofibromatosis1thedanishnf1cohort
AT hovehanne cohortprofilelifewithneurofibromatosis1thedanishnf1cohort
AT østergaardjohnr cohortprofilelifewithneurofibromatosis1thedanishnf1cohort
AT bidstruppernillee cohortprofilelifewithneurofibromatosis1thedanishnf1cohort
AT daltonsusanneo cohortprofilelifewithneurofibromatosis1thedanishnf1cohort
AT handrupmettemøller cohortprofilelifewithneurofibromatosis1thedanishnf1cohort
AT ejerskovcecilie cohortprofilelifewithneurofibromatosis1thedanishnf1cohort
AT krøyeranja cohortprofilelifewithneurofibromatosis1thedanishnf1cohort
AT dohertymiaaagaard cohortprofilelifewithneurofibromatosis1thedanishnf1cohort
AT møllegaardjepsenjensrichardt cohortprofilelifewithneurofibromatosis1thedanishnf1cohort
AT mulvihilljohnj cohortprofilelifewithneurofibromatosis1thedanishnf1cohort
AT wintherjeanettef cohortprofilelifewithneurofibromatosis1thedanishnf1cohort
AT kenborgline cohortprofilelifewithneurofibromatosis1thedanishnf1cohort